Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ELDNELDN
15 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ELEDON PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 215,973 shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $850,934 as of 2026-Q2. This is a new position. ELDN represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$850,934

Current Shares

215,973

Total Value Change

+$582,934

Total Shares Change

+190,911

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
215,973
-
$850,9340.0%$3.94
34
2025-Q3
Exited
0
-100.0%
$00.0%$2.54
0
2025-Q2
Increased
152,460
+62.2%
$413,1670.0%$2.69
35
2025-Q1
Decreased
93,997
-50.5%
$318,6500.0%$3.35
0
2024-Q4
New
189,870
-
$782,2640.0%$4.14
34
2024-Q2
Exited
0
-100.0%
$00.0%$2.64
0
2024-Q1
Decreased
15,982
-31.1%
$32,9230.0%$2.06
0
2023-Q4
New
23,208
-
$41,7740.0%$1.80
31
2023-Q3
Exited
0
-100.0%
$00.0%$1.37
0
2023-Q2
Decreased
7,740
-74.9%
$10,6040.0%$1.42
0
2023-Q1
New
30,810
-
$72,7120.0%$2.51
32
2022-Q1
Exited
0
-100.0%
$00.0%$3.90
0
2021-Q4
New
10,174
-
$45,0000.0%$4.36
31
2021-Q2
Exited
0
-100.0%
$00.0%$7.97
0
2021-Q1
New
25,062
-
$268,0000.0%$9.85
32

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used